The European Medicines Agency says the benefits of the shot outweigh the risks after several countries pause rollouts amid fears over blood clots.
The European Medicines Agency says the benefits of the shot outweigh the risks after several countries pause rollouts amid fears over blood clots.
Norway, Sweden and Denmark will wait before restarting AstraZeneca COVID-19 vaccinations despite the EU regulator's verdict that..